Please provide your email address to receive an email when new articles are posted on . CHICAGO — A new combination therapy benefitted certain patients with immunotherapy-resistant advanced non-small ...
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or ...
Long-term survivorship rates among patients with previously treated advanced renal cell carcinoma receiving nivolumab: Analyses based on ≥ 7 years of follow-up from CheckMate 025 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback